No statistically significant differences were found between the two groups in terms of gender, age, duration of TAO, CAS score, TAO-QOL score, TRAb, IL-6, and CD4+/CD8+(P>0.05; Table 1). This evidence concerns the gene CD8A and thromboangiitis obliterans.